Back to Careers

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Back to Careers

Lilly Bites Again in $650M Muscle-Preserving Treatment Pact With Juvena

Back to Careers

Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs

Back to Careers

Juvena Kicks Off First Human Trial of Muscle Regeneration Therapy

Back to Careers

Our CEO, Hanadie Yousef, discussed Juvena’s growing and advancing pipeline of tissue restorative biologics for myopathies and obesity with Miranda Schmalfuhs from Pharmaceutical Executive

Back to Careers

Healthspan Capital highlights Juvena Therapeutics in its LongBio Report comprehensively profiling the leading companies in longevity biotechnology

Back to Careers

CEO Dr. Hanadie Yousef was nominated to Founders Forum’s 100 Women Founders to Watch,  which shines a light on 100 of the most exceptional women founders blazing a trail in the tech industry across UK & Europe, the United States, and Southeast Asia

Back to Careers

Longevity Technology highlights Juvena and others from the Longevity Summer Dublin

Back to Careers

Juvena is selected by the World Economic Forum to join its 2024 global cohort of Technology Pioneers, awarded to the 100 most innovative tech startups applying new breakthroughs in AI to solve some of the biggest challenges of our time.

Back to Careers

CEO and co-Founder Dr. Hanadie Yousef recognized as In Vivo’s 2024 Rising Leaders, which includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.